Haemonetics Corporation (HAE)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:46AM EDT. Market open.
| Previous close | 93.33 |
| Open | 94.52 |
| Bid | 93.24 x 800 |
| Ask | 93.51 x 1000 |
| Day's range | 93.09 - 94.48 |
| 52-week range | 70.74 - 95.26 |
| Volume | |
| Avg. volume | 487,435 |
| Market cap | 4.74B |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | 37.94 |
| EPS (TTM) | 2.46 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 105.57 |
ZacksHaemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
Simply Wall St.Is Haemonetics Corporation's (NYSE:HAE) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Haemonetics' (NYSE:HAE) stock is up by a considerable 12% over the past month. Given the company's impressive...
ZacksWhy You Should Add Haemonetics (HAE) to Your Portfolio Now
Recovery within the Hospital business and the favorable prospects of the Plasma franchise raise investors' optimism for Haemonetics (HAE).
© 2024 Yahoo. All rights reserved.